Question 1

What is EFLAPEGRASTIM-XNST used for?

Accepted Answer

EFLAPEGRASTIM-XNST (brand name Rolvedon) is a Other indicated for 1 INDICATIONS AND USAGE Rolvedon is indicated to decrease the incidence of infection, as manifested by febrile neutropenia, as manifested by febrile neutropenia.

Question 2

How does EFLAPEGRASTIM-XNST work?

Accepted Answer

EFLAPEGRASTIM-XNST works through the following mechanism: 12.1 Mechanism of Action Eflapegrastim-xnst is a recombinant human granulocyte growth factor that binds to G-CSF receptors on myeloid progenitor cells and neutrophils, triggering signaling pathways that control cell differentiation, proliferation, migration and survival..

Question 3

What are the most common side effects of EFLAPEGRASTIM-XNST?

Accepted Answer

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for EFLAPEGRASTIM-XNST. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Question 4

Is EFLAPEGRASTIM-XNST the same as Rolvedon?

Accepted Answer

Rolvedon is a brand name for EFLAPEGRASTIM-XNST. They share the same active ingredient and FDA-approved indications. Biosimilars and authorised generics may differ in inactive ingredients such as buffers or preservatives.

EFLAPEGRASTIM-XNST

Mechanism of Action

Indications

FDA Warnings

Known Side Effects

Community Discussions

Primary sources

Compare With

Formulations